Dolby Laboratories Reports Second Quarter 2024 Financial Results

SAN FRANCISCO, May 2, 2024 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the second quarter of fiscal 2024.

"Our second quarter results were in line with our expectations," said Kevin Yeaman, President and CEO, Dolby Laboratories. "Dolby Atmos and Dolby Vision content is expanding across movies, TV, sports, music and more, driving more consumer device adoption and bringing Dolby to more people worldwide."

Second Quarter Fiscal 2024 Financial Highlights

    --  Total revenue was $364.5 million, compared to $375.9 million for the
        second quarter of fiscal 2023.
    --  GAAP net income was $97.8 million, or $1.01 per diluted share, compared
        to GAAP net income of $95.7 million, or $0.98 per diluted share, for the
        second quarter of fiscal 2023. On a non-GAAP basis, second quarter net
        income was $123.2 million, or $1.27 per diluted share, compared to
        $122.6 million, or $1.26 per diluted share, for the second quarter of
        fiscal 2023.
    --  Dolby repurchased 294 thousand shares of its common stock and ended the
        quarter with approximately $107 million of stock repurchase
        authorization available going forward.

A complete listing of Dolby's non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release.

Recent Business Highlights

    --  Max announced the launch of Dolby Vision for live sports in addition to
        Dolby Atmos.
    --  The Indian Premier League broadcasted cricket in Dolby Atmos and Dolby
        Vision for the first time.
    --  Transsion, a global mobile device maker, announced that their latest
        smartphones will support Dolby Atmos.
    --  Xiaomi expanded its premium smartphone portfolio in India with
        smartphones supporting Dolby Vision Capture, Dolby Vision, and Dolby
        Atmos.
    --  Oppo recently announced that they introduced five new phones supporting
        Dolby Vision Capture.
    --  Honor launched the Magic 6 Pro smartphone that supports Dolby Vision.
    --  Lava Mobiles launched its new Blaze Curve 5G smartphone in India that
        supports Dolby Atmos.
    --  Xiaomi also announced that their first electric vehicle, the SU7, will
        support Dolby Atmos.
    --  Automotive manufacturer Hyundai began shipping its Genesis model that
        supports Dolby Atmos.

Dividend

Today, Dolby announced a cash dividend of $0.30 per share of Class A and Class B common stock, payable on May 22, 2024, to stockholders of record as of the close of business on May 14, 2024.

Financial Outlook

Dolby's financial outlook relies, in part, on estimates of royalty-based revenue that take into consideration various factors that are subject to uncertainty, including consumer demand for electronic products. In addition, actual results could differ materially from the estimates Dolby is providing below due in part to uncertainty resulting from the macroeconomic effect of certain conditions, including supply chain constraints, international conflicts, geopolitical instability, and fluctuations in inflation and interest rates. The uncertainty resulting from these factors has greatly reduced its visibility into Dolby's future outlook. To the extent possible, the estimates Dolby is providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are subject to risks and uncertainties. For more information, see "Forward-Looking Statements" in this press release for a description of certain risks that Dolby faces, and the section captioned "Risk Factors" in its Quarterly Report on Form 10-Q for the second quarter of fiscal 2024, to be filed on or around the date hereof.

Dolby is providing the following estimates for its third quarter of fiscal 2024:

    --  Total revenue is estimated to range from $270 million to $300 million.
    --  Licensing revenue is estimated to range from $245 million to $275
        million.
    --  Gross margins are anticipated to be approximately 87%.
    --  Operating expenses are anticipated to range from $215 million to $225
        million on a GAAP basis and from $180 million to $190 million on a
        non-GAAP basis.
    --  Effective tax rate is anticipated to be around 24% on a GAAP basis and
        around 21% on a non-GAAP basis.
    --  Diluted earnings per share is anticipated to range from $0.21 to $0.36
        on a GAAP basis and from $0.51 to $0.66 on a non-GAAP basis.

Dolby is providing the following estimates for the full year of fiscal 2024:

    --  Total revenue is expected to be roughly $1.30 billion.
    --  Gross margins are anticipated to be roughly 89%.
    --  Operating expenses are anticipated to range from $885 million to $895
        million on a GAAP basis and from $740 million to $750 million on a
        non-GAAP basis.
    --  Dolby expects operating margins on a GAAP basis to be roughly 20% and on
        a non-GAAP basis to be roughly 32%.
    --  Diluted earnings per share is anticipated to range from $2.30 to $2.45
        on a GAAP basis and from $3.60 to $3.75 on a non-GAAP basis.

Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss second quarter fiscal 2024 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, May 2, 2024. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-210-2212 (+1-646-960-0390 for international callers) and entering confirmation code 5587811.

A replay of the call will be available from 5:00 p.m. PT (8:00 p.m. ET) on Thursday, May 2, 2024, until 8:59 p.m. PT (11:59 p.m. ET) on Tuesday, May 7, 2024 by dialing 1-800-770-2030 (+1-647-362-9199 for international callers) and entering the confirmation code 5587811. An archived version of the teleconference will also be available on the Dolby website, http://investor.dolby.com.

Non-GAAP Financial Information

To supplement Dolby's financial statements presented on a GAAP basis, Dolby management uses, and Dolby provides to investors, certain non-GAAP financial measures as an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations and performance. We believe these non-GAAP financial measures are also helpful to investors in enabling comparability of operating performance between periods and among peer companies. Additionally, Dolby's management regularly uses our supplemental non-GAAP financial measures to make operating decisions, for planning and forecasting purposes and determining bonus payouts. Specifically, Dolby excludes the following as adjustments from one or more of its non-GAAP financial measures:

Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that Dolby grants. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between its underlying operating results and those of other companies, Dolby excludes stock-based compensation expense.

Amortization of acquisition-related intangibles: Dolby amortizes intangible assets acquired in connection with acquisitions. These intangible assets consist of patents and technology, customer relationships, and other intangibles. Dolby records amortization charges relating to these intangible assets in its GAAP financial statements, and Dolby views these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of its acquisitions. As these amortization charges do not directly correlate to its operations during any particular period, Dolby excludes these charges to facilitate an evaluation of its current operating performance and comparisons to its past operating results. In addition, while amortization expense of acquisition-related intangible assets is excluded from Non-GAAP Net Income, the revenue generated from those assets is not excluded.

Restructuring charges or credits: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. Dolby excludes restructuring costs, including any adjustments to charges recorded in prior periods (which may be credits), as Dolby believes that these costs are not representative of its normal operating activities and therefore, excluding these amounts enables a more effective comparison of its past operating performance and to that of other companies.

Income tax adjustments: The income tax effects of the aforementioned non-GAAP adjustments do not directly correlate to its operating performance so Dolby believes that excluding such income tax effects provides a more meaningful view of its underlying operating results to management and investors.

Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby's management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby's business, including as a means to evaluate period-to-period comparisons. Dolby's management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above and below. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.

Forward-Looking Statements

Certain statements in this press release and in our earnings calls, including, but not limited to, expected financial results for the third quarter of fiscal 2024 and full year fiscal 2024, Dolby's ability to expand existing business, navigate challenging periods, pursue its long-term growth opportunities, and advance its other long-term objectives are "forward-looking statements" that inherently involve substantial risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of economic conditions on Dolby's business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; the level at which Dolby technologies are incorporated into products and the consumer demand for such products; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; lengthening sales cycles; the impact to the overall cinema market including adverse impact to Dolby's revenue recognized on box-office sales and demand for cinema products and services; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with geopolitical issues and international conflicts; risks associated with trends in the markets in which Dolby operates, including the broadcast, mobile, consumer electronics, PC, and other markets; the loss of, or reduction in sales by, a key customer, partner, or licensee? pricing pressures? risks relating to changing trends in the way that content is distributed and consumed; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to maintaining patent coverage? the timing of Dolby's receipt of royalty reports and payments from its licensees, including recoveries? changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements? Dolby's ability to develop, maintain, and strengthen relationships with industry participants? Dolby's ability to develop and deliver innovative products and technologies in response to new and growing markets? competitive risks? risks associated with conducting business in China and other countries that have historically limited recognition and enforcement of intellectual property and contractual rights? risks associated with the health of the motion picture and cinema industries generally, including the potential impacts of the recent strikes by the WGA and SAG-AFTRA? Dolby's ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond its current technology offerings? risks associated with acquiring and successfully integrating businesses or technologies? and other risks detailed in Dolby's SEC filings and reports, including the risks identified under the section captioned "Risk Factors" in its Quarterly Report on Form 10-Q filed on or around the date hereof. Dolby may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements. Forward-looking statements are based upon information available to us as of the date of such statements, and while Dolby believes such information forms a reasonable basis for such statements, such information may be limited or incomplete. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Except as required by law, Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby Laboratories

Dolby Laboratories (NYSE: DLB) is based in San Francisco, California with offices around the globe. From movies and TV shows, to apps, music, sports and gaming, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide. Dolby partners with artists, storytellers, developers, and businesses to revolutionize entertainment and communications with Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby.io.

Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby.io, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories in the United States and/or other countries. Other trademarks remain the property of their respective owners.


                                                                         
            
              DOLBY LABORATORIES, INC.


                                                              
            
          INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS


                                                            
            (
        in thousands, except per share amounts; unaudited
            )




                                                                                                                                           Fiscal Quarter Ended                 Fiscal Year-To-Date Ended


                                                                                                                                 March 29,                      March 31,  March 29,                      March 31,
                                                                                                                                      2024                            2023        2024                            2023



     
              Revenue:



     Licensing                                                                                                                   $338,240                        $351,608    $632,007                        $659,619



     Products and services                                                                                                         26,283                          24,283      48,090                          51,193



     Total revenue                                                                                                                364,523                         375,891     680,097                         710,812





     
              Cost of revenue:



     Cost of licensing                                                                                                             15,318                          21,365      31,054                          34,724



     Cost of products and services                                                                                                 23,459                          19,684      39,783                          40,775



     Total cost of revenue                                                                                                         38,777                          41,049      70,837                          75,499





     
              Gross profit                                                                                                      325,746                         334,842     609,260                         635,313





     
              Operating expenses:



     Research and development                                                                                                      62,493                          67,951     129,526                         132,401



     Sales and marketing                                                                                                           90,038                          95,695     169,041                         177,900



     General and administrative                                                                                                    66,742                          61,939     131,908                         121,911



     Restructuring charges/(credits)                                                                                              (2,495)                             33       3,596                           (211)



     Total operating expenses                                                                                                     216,778                         225,618     434,071                         432,001





     
              Operating income                                                                                                  108,968                         109,224     175,189                         203,312





     
              Other income/(expense):



     Interest income/(expense), net                                                                                                 8,597                           6,807      17,784                          11,604



     Other income, net                                                                                                              4,183                           1,250       9,608                           2,347



     Total other income                                                                                                            12,780                           8,057      27,392                          13,951





     Income before income taxes                                                                                                   121,748                         117,281     202,581                         217,263



     Provision for income taxes                                                                                                  (23,534)                       (21,398)   (36,786)                       (41,932)



     Net income including noncontrolling interest                                                                                  98,214                          95,883     165,795                         175,331



     Less: net income attributable to noncontrolling interest                                                                       (384)                          (187)      (984)                          (260)



     
              Net income attributable to Dolby Laboratories, Inc.                                                               $97,830                         $95,696    $164,811                        $175,071





     Net income per share:



     Basic                                                                                                                          $1.02                           $1.00       $1.72                           $1.83



     Diluted                                                                                                                        $1.01                           $0.98       $1.69                           $1.80



     Weighted-average shares outstanding:



     Basic                                                                                                                         95,718                          95,820      95,547                          95,862



     Diluted                                                                                                                       96,856                          97,298      97,397                          97,392


                                         
              
                DOLBY LABORATORIES, INC.


                              
              
                INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS


                                    
              (
              in thousands; unaudited
              )




                                                                                                     March 29, September 29,
                                                                                                          2024           2023



     
                ASSETS



     Current assets:



     Cash and cash equivalents                                                                       $709,535       $745,364



     Restricted cash                                                                                  114,821         72,602



     Short-term investments                                                                           115,863        139,148



     Accounts receivable, net                                                                         282,131        262,245



     Contract assets, net                                                                             243,170        182,130



     Inventories, net                                                                                  35,797         35,623



     Prepaid expenses and other current assets                                                         50,421         50,692



     Total current assets                                                                           1,551,738      1,487,804



     Long-term investments                                                                            127,973         97,812



     Property, plant, and equipment, net                                                              481,492        481,581



     Operating lease right-of-use assets                                                               43,057         40,199



     Goodwill and intangible assets, net                                                              560,801        575,836



     Deferred taxes                                                                                   208,494        201,860



     Other non-current assets                                                                          71,173         94,674



     
                Total assets                                                                     $3,044,728     $2,979,766





     
                LIABILITIES AND STOCKHOLDERS' EQUITY



     Current liabilities:



     Accounts payable                                                                                 $19,727        $20,925



     Accrued liabilities                                                                              362,883        351,399



     Income taxes payable                                                                               8,384          4,769



     Contract liabilities                                                                              37,702         31,505



     Operating lease liabilities                                                                       14,206         13,628



     Total current liabilities                                                                        442,902        422,226



     Non-current contract liabilities                                                                  36,453         39,997



     Non-current operating lease liabilities                                                           37,711         37,020



     Other non-current liabilities                                                                     89,975        108,339



     Total liabilities                                                                                607,041        607,582





     Stockholders' equity:



     Class A common stock                                                                                  53             53



     Class B common stock                                                                                  41             41



     Retained earnings                                                                              2,449,876      2,391,990



     Accumulated other comprehensive loss                                                            (29,068)      (36,984)



     Total stockholders' equity - Dolby Laboratories, Inc.                                          2,420,902      2,355,100



     Noncontrolling interest                                                                           16,785         17,084



     Total stockholders' equity                                                                     2,437,687      2,372,184



     
                Total liabilities and stockholders' equity                                       $3,044,728     $2,979,766


                                                                             
              
                DOLBY LABORATORIES, INC.


                                                             
              
                INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS


                                                                        
              (
              in thousands; unaudited
              )




                                                                                                                                                      Fiscal Year-To-Date Ended


                                                                                                                                             March 29,                          March 31,
                                                                                                                                                  2024                                2023



     
                Operating activities:



     Net income including noncontrolling interest                                                                                            $165,795                            $175,331



     Adjustments to reconcile net income to net cash provided by operating activities:



     Depreciation and amortization                                                                                                             35,890                              40,388



     Stock-based compensation                                                                                                                  60,809                              61,067



     Amortization of operating lease right-of-use assets                                                                                        5,847                               6,565



     Amortization of premium on investments                                                                                                   (1,757)                                 37



     Benefit from credit losses                                                                                                               (1,454)                            (2,072)



     Deferred income taxes                                                                                                                    (6,779)                           (19,544)



     Other non-cash items affecting net income                                                                                                (2,500)                            (4,417)



     Changes in operating assets and liabilities:



     Accounts receivable, net                                                                                                                (18,509)                           (37,769)



     Contract assets, net                                                                                                                    (61,008)                           (99,162)



     Inventories                                                                                                                              (7,836)                            (4,728)



     Operating lease right-of-use assets                                                                                                      (7,848)                            (2,643)



     Prepaid expenses and other assets                                                                                                         33,527                              12,943



     Accounts payable and accrued liabilities                                                                                                   3,923                              21,609



     Income taxes, net                                                                                                                          5,215                              17,370



     Contract liabilities                                                                                                                       2,651                               3,852



     Operating lease liabilities                                                                                                                1,028                             (5,415)



     Other non-current liabilities                                                                                                           (17,176)                            (2,475)



     Net cash provided by operating activities                                                                                                189,818                             160,937





     
                Investing activities:



     Purchases of marketable securities                                                                                                     (104,135)                           (80,561)



     Proceeds from sales of marketable securities                                                                                               4,451                              52,345



     Proceeds from maturities of marketable securities                                                                                         97,459                              94,843



     Purchases of property, plant, and equipment                                                                                             (15,015)                           (14,741)



     Net cash provided by (used in) investing activities                                                                                     (17,240)                             51,886





     
                Financing activities:



     Proceeds from issuance of common stock                                                                                                    29,345                              21,394



     Repurchase of common stock                                                                                                             (104,999)                           (99,276)



     Payment of cash dividend                                                                                                                (57,268)                           (51,741)



     Distribution to noncontrolling interest                                                                                                  (1,047)                              (266)



     Shares repurchased for tax withholdings on vesting of restricted stock                                                                  (36,054)                           (26,800)



     Equity issued in connection with business combination                                                                                        722



     Payment of deferred consideration for prior business combinations                                                                              -                              (500)



     Net cash used in financing activities                                                                                                  (169,301)                          (157,189)





     Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash                                                     3,113                               9,415



     Net increase/(decrease) in cash, cash equivalents, and restricted cash                                                                     6,390                              65,049



     Cash, cash equivalents, and restricted cash at beginning of period                                                                       817,966                             628,371



     Cash, cash equivalents, and restricted cash at end of period                                                                            $824,356                            $693,420


                                                                                                                                   
              
                GAAP to Non-GAAP Reconciliations


                                                                                                                                             
              
                (unaudited)





     The following tables present Dolby's GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the second quarter and year-to-date periods ended March 29, 2024 and March 31, 2023:





     
                Net income:                                                                                                                                                                                                     
       
              Fiscal Quarter Ended                        Fiscal Year-To-Date Ended



     
                (in thousands)                                                                                                                                                                                                       March 29,                        March 31,    March 29,                            March 31,
                                                                                                                                                                                                                                             2024                              2023          2024                                   2023



     GAAP net income attributable to Dolby Laboratories, Inc.                                                                                                                                                                            $97,830                           $95,696      $164,811                               $175,071



     Stock-based compensation (1)                                                                                                                                                                                                         28,915                            29,827        60,809                                 61,067



     Amortization of acquisition-related intangibles (2)                                                                                                                                                                                   3,031                             2,372         6,155                                  3,719



     Restructuring charges/(credits)                                                                                                                                                                                                     (2,495)                               33         3,596                                  (211)



     Income tax adjustments                                                                                                                                                                                                              (4,091)                          (5,367)     (13,541)                               (9,655)



     Non-GAAP net income attributable to Dolby Laboratories, Inc.                                                                                                                                                                       $123,190                          $122,561      $221,830                               $229,991





     (1) Stock-based compensation included in above line items:



     Cost of products and services                                                                                                                                                                                                          $356                              $432          $766                                   $934



     Research and development                                                                                                                                                                                                              8,949                             9,473        19,055                                 20,148



     Sales and marketing                                                                                                                                                                                                                   9,927                            10,275        20,408                                 21,003



     General and administrative                                                                                                                                                                                                            9,683                             9,647        20,580                                 18,982





     (2) Amortization of acquisition-related intangibles included in above line items:



     Cost of licensing                                                                                                                                                                                                                     $(15)                              $62           $47                                   $123



     Cost of products and services                                                                                                                                                                                                           524                               866         1,058                                  1,733



     Research and development                                                                                                                                                                                                                                                 126                                                 254



     Sales and marketing                                                                                                                                                                                                                     650                               805         1,306                                  1,609



     General and administrative                                                                                                                                                                                                            1,872                               513         3,744





     
                Diluted earnings per share:                                                                                                                                                                                     
       
              Fiscal Quarter Ended                        Fiscal Year-To-Date Ended


                                                                                                                                                                                                                                        March 29,                        March 31,    March 29,                            March 31,
                                                                                                                                                                                                                                             2024                              2023          2024                                   2023



     GAAP diluted earnings per share                                                                                                                                                                                                       $1.01                             $0.98         $1.69                                  $1.80



     Stock-based compensation                                                                                                                                                                                                               0.30                              0.31          0.63                                   0.63



     Amortization of acquisition-related intangibles                                                                                                                                                                                        0.03                              0.02          0.06                                   0.03



     Restructuring charges                                                                                                                                                                                                                (0.03)                                          0.04



     Income tax adjustments                                                                                                                                                                                                               (0.04)                           (0.05)       (0.14)                                (0.10)



     Non-GAAP diluted earnings per share                                                                                                                                                                                                   $1.27                             $1.26         $2.28                                  $2.36







     Weighted-average shares outstanding - diluted (in thousands)                                                                                                                                                                         96,856                            97,298        97,397                                 97,392





     The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial measures for the third quarter of fiscal 2024 and full year fiscal 2024 included in this release:





     
                Operating expenses (in millions):                                                                                                                                                                                                                      Q3 2024                                         Fiscal 2024



     GAAP operating expenses (low - high end of range)                                                                                                                                                                                                      
             $215 - $225                             
              $885 - $895



     Stock-based compensation                                                                                                                                                                                                                                                (32)                                              (128)



     Amortization of acquisition-related intangibles                                                                                                                                                                                                                          (3)                                               (13)



     Restructuring charges                                                                                                                                                                                                                                                                                                       (4)



     Non-GAAP operating expenses (low - high end of range)                                                                                                                                                                                                  
             $180 - $190                             
              $740 - $750





     
                Operating margin:                                                                                                                                                                                                                                                                                    Fiscal 2024



     GAAP operating margin                                                                                                                                                                                                                                                                                        
              20% +/-



     Stock-based compensation                                                                                                                                                                                                                                                                                                   10 %



     Amortization of acquisition-related intangibles                                                                                                                                                                                                                                                                             1 %



     Restructuring charges                                                                                                                                                                                                                                                                                                       1 %



     Non-GAAP operating margin                                                                                                                                                                                                                                                                                    
              32% +/-









     
                Effective tax rate:                                                                                                                                                                                                                                                                                      Q3 2024



     GAAP effective tax rate                                                                                                                                                                                                                                                                                                    24 %



     Stock-based compensation (low - high end of range)                                                                                                                                                                                                                                                                    (2%) - 0%



     Amortization of acquisition-related intangibles (low - high end of range)                                                                                                                                                                                                                                             (1%) - 0%



     Non-GAAP effective tax rate                                                                                                                                                                                                                                                                                                21 %





     
                Diluted earnings per share:                                                                                                                                                                                       
            
              Q3 2024                    
       
                Fiscal 2024


                                                                                                                                                                                                                                           Low                              High         Low                                  High



     GAAP diluted earnings per share                                                                                                                                                                                                       $0.21                             $0.36         $2.30                                  $2.45



     Stock-based compensation                                                                                                                                                                                                               0.33                              0.33          1.30                                   1.30



     Amortization of acquisition-related intangibles                                                                                                                                                                                        0.03                              0.03          0.14                                   0.14



     Restructuring charges                                                                                                                                                                                                                                                                0.04                                   0.04



     Income tax adjustments                                                                                                                                                                                                               (0.06)                           (0.06)       (0.18)                                (0.18)



     Non-GAAP diluted earnings per share                                                                                                                                                                                                   $0.51                             $0.66         $3.60                                  $3.75





     Weighted-average shares outstanding - diluted (in thousands)                                                                                                                                                                         97,300                            97,300        97,600                                 97,600

Investor Contact:
Peter Goldmacher
415-254-7415
peter.goldmacher@dolby.com

Media Contact:
Rachel Lowery
media@dolby.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/dolby-laboratories-reports-second-quarter-2024-financial-results-302135069.html

SOURCE Dolby Laboratories, Inc.